Our industry-leading neuroscience portfolio includes FDA-approved treatments for major depressive disorder, agitation associated with dementia due to Alzheimer’s disease, excessive daytime sleepiness associated with narcolepsy and obstructive sleep apnea, and migraine, as well as multiple novel product candidates addressing a broad range of serious neurological and psychiatric conditions that impact over 150 million people in the United States. The Manager will work closely with Sales Training leadership, field leaders, and cross-functional partners to deliver approved training content, manage training logistics, track completion, and ensure a consistent, high-quality onboarding experience for new hires.